Thorax is one of the world's leading respiratory medicine journals publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax is one of the highest ISI ranked journals covering all aspects of pulmonary medicine. Each issue covers topics such as COPD, asthma, smoking, respiratory infection and lung cancer; and includes editorials, short papers, review series, case reports, images in thorax, and letters.

Thorax seeks to publish significant advances in scientific understanding which are likely to impact on clinical practice. Articles concerning clinical topics, critical care, and those on basic mechanisms with application to clinical material, will be welcomed. We aim to cover all areas of respiratory medicine (epidemiology, paediatrics, immunology, pharmacology, pathology, surgery and critical care) through publishing original papers, editorials, reviews, case reports and images. The priorities are originality and excellence.

All submissions are subject to peer review. All papers that are potentially acceptable undergo statistical analysis.

Submissions to Thorax, once peer reviewed, are discussed at the weekly editorial committee prior to decision. We aim to ensure a fair and independent peer review system and to publish articles which follow the highest ethical standards concerning research conduct.

Please click here to view the Impact Factor.

1. Median time from submission to first decision = 6 weeks
   1. 30% of papers rejected without external peer review within 2 weeks
2. Time from acceptance to publication = 4 months
   1. Full original articles published Online First within 2 weeks